Cangrelor tetrasodium
Cangrelor tetrasodium is a potent, reversible P2Y12 receptor antagonist that provides rapid antiplatelet action. It is widely used in cardiovascular research to study thrombosis and platelet biology in both in vitro assays and in vivo animal models.
Product Specifications
CAS Number
163706-36-3
Product Name Alternative
Platelet, pulmonary, P2Y Receptor, P2Y, P2YReceptor, aggregation, antiplatelet, cangrelor tetrasodium, cangrelor, GPR17, fibrosis, Inhibitor, inflammation, intravenous, inhibit
Field of Research
Metabolism Research, Neuroscience, Pharmacology & Drug Discovery
Purity
98.51% (May vary between batches)
Solubility
H2O:80 mg/mL (92.56 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.16 mM) ; DMSO:12.56 mg/mL (14.53 mM)
Smiles
[Na+].[Na+].[Na+].[Na+].CSCCNc1nc (SCCC (F) (F) F) nc2n (cnc12) [C@@H]1O[C@H] (COP ([O-]) (=O) OP ([O-]) (=O) C (Cl) (Cl) P ([O-]) ([O-]) =O) [C@@H] (O) [C@H]1O
Molecular Formula
C17H21Cl2F3N5Na4O12P3S2
Molecular Weight
864.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
035827-APC 200 µL
G3BP1, CT (G3BP1, G3BP, Ras GTPase-activating protein-binding protein 1, ATP-dependent DNA helicase VIII, GAP SH3 domain-binding protein 1) (APC) discontinued
Sign In for Pricing
View Details